

(Sharecast News) - Silence Therapeutics announced on Thursday that the first patient has been dosed in the 'GEMINI II' phase 1 clinical study of its w...


IN BRIEF: Silence Therapeutics achieves further Mallinckrodt milestone


(Sharecast News) - Silence Therapeutics has achieved another research milestone as part of its ongoing RNAi collaboration with Mallinckrodt for comple...


DIRECTOR DEALINGS: Silence Therapeutics top team buy USD540,000 worth


TRADING UPDATES: Numis expects interim revenue rise; Dods profit swing


UK earnings, trading statements calendar - next 7 days


LONDON TRADING UPDATES: Castings Hails Return To Pre-Covid Levels


(Sharecast News) - Silence Therapeutics announced on Friday that it would receive a $2m (£1.43m) milestone payment following the start of work on...